Want to see KRSA full AI Analyst Report?
Total Valuation
Korsana Biosciences has a market cap or net worth of $16.42M. The enterprise value is $2.28.
Market Cap$16.42M
Enterprise Value$2.28
Share Statistics
Korsana Biosciences has 668,764 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding668,764
Owned by Insiders22.28%
Owned by Institutions―
Financial Efficiency
Korsana Biosciences’s return on equity (ROE) is -0.39 and return on invested capital (ROIC) is -54.74%.
Return on Equity (ROE)-0.39
Return on Assets (ROA)-0.35
Return on Invested Capital (ROIC)-54.74%
Return on Capital Employed (ROCE)-0.55
Revenue Per Employee2.07M
Profits Per Employee-3.53M
Employee Count1
Asset Turnover0.21
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Korsana Biosciences is ―. Korsana Biosciences’s PEG ratio is 0.12.
PE Ratio―
PS Ratio1.97
PB Ratio0.45
Price to Fair Value0.45
Price to FCF-1.24
Price to Operating Cash Flow-4.35
PEG Ratio0.12
Income Statement
In the last 12 months, Korsana Biosciences had revenue of 2.07M and earned -3.53M in profits. Earnings per share was -7.63.
Revenue2.07M
Gross Profit2.07M
Operating Income-4.97M
Pretax Income-3.53M
Net Income-3.53M
EBITDA-3.53M
Earnings Per Share (EPS)-7.63
Cash Flow
In the last 12 months, operating cash flow was -4.45M and capital expenditures 0.00, giving a free cash flow of -4.45M billion.
Operating Cash Flow-4.45M
Free Cash Flow-4.45M
Free Cash Flow per Share-6.66
Dividends & Yields
Korsana Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.60
52-Week Price Change85.28%
50-Day Moving Average26.47
200-Day Moving Average18.19
Relative Strength Index (RSI)57.65
Average Volume (3m)10.63K
Important Dates
Korsana Biosciences upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Korsana Biosciences as a current ratio of 5.15, with Debt / Equity ratio of 0.00%
Current Ratio5.15
Quick Ratio5.15
Debt to Market Cap0.00
Net Debt to EBITDA0.92
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Korsana Biosciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Korsana Biosciences EV to EBITDA ratio is -0.24, with an EV/FCF ratio of -0.26.
EV to Sales0.41
EV to EBITDA-0.24
EV to Free Cash Flow-0.26
EV to Operating Cash Flow-0.26
Balance Sheet
Korsana Biosciences has $1.39M in cash and marketable securities with $0.00 in debt, giving a net cash position of $1.39M billion.
Cash & Marketable Securities$1.39M
Total Debt$0.00
Net Cash$1.39M
Net Cash Per Share$2.08
Tangible Book Value Per Share$19.72
Margins
Gross margin is 61.58%, with operating margin of -239.78%, and net profit margin of -170.11%.
Gross Margin61.58%
Operating Margin-239.78%
Pretax Margin-170.11%
Net Profit Margin-170.11%
EBITDA Margin-170.11%
EBIT Margin-170.11%
Analyst Forecast
The average price target for Korsana Biosciences is $55.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$55.00
Price Target Upside1225.30% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-12.60%
EPS Growth Forecast-126.24%